Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve

被引:0
作者
E. V. Khokhlova
B. A. Efimov
L. I. Kafarskaia
A. N. Shkoporov
机构
[1] Russian State Medical University,Department of Microbiology and Virology
来源
Archives of Microbiology | 2010年 / 192卷
关键词
Inflammatory bowel disease; Interleukin-10; Vector;
D O I
暂无
中图分类号
学科分类号
摘要
Construction of Bifidobacterium breve capable of production of secreted biologically active human interleukin-10 (hIL-10) is described. ORF coding for full-length mature human interleukin-10 was cloned into a series of expression vectors. This resulted in generation of translational fusions between hIL-10 and signal peptides sequences derived from Bifidobacterium breve genes sec2, apuB and B. adolescentis gene amyB under the control of constitutively active bifidobacterial promoter. We have shown that fusion to amyB signal peptide resulted in highest expression level of hIL-10 at the mRNA and protein level. Secreted hIL-10 was highly unstable in bifidobacterial culture supernatants in standard growth conditions. However, incubation of stationary cultures in buffered tissue culture medium resulted in production of stable biologically active hIL-10, albeit in low amounts (1.9 ng/ml).
引用
收藏
页码:769 / 774
页数:5
相关论文
共 111 条
[1]  
Allen SJ(2010)Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy J Nutr 140 483-488
[2]  
Jordan S(2000)Interleukin 10 gene transfer prevents experimental colitis in rats Gut 46 344-349
[3]  
Storey M(2003)Interleukin-10-based therapy for inflammatory bowel disease Expert Opin Biol Ther 3 725-731
[4]  
Thornton CA(2006)A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease Clin Gastroenterol Hepatol 4 754-759
[5]  
Gravenor M(2008)Bifidobacterial plasmids and their application to genetic engineering Vestn Ross Akad Med Nauk 2 16-21
[6]  
Garaiova I(2003)Development of bacterial and bifidobacterial communities in feces of newborn babies Anaerobe 9 219-229
[7]  
Plummer SF(2000)Probiotic bacteria: today and tomorrow J Nutr 130 415-416
[8]  
Wang D(2000)The characteristics of biological preparations and food additives for functional nutrition and the correction of the intestinal microflora Zh Mikrobiol Epidemiol Immunobiol 3 86-91
[9]  
Morgan G(2008)Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial Pediatrics 122 8-12
[10]  
Barbara G(2005)Secretion of recombinant pediocin PA-1 by Appl Environ Microbiol 71 5630-5632